Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-6-29
pubmed:abstractText
Combined treatment with anti-thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves' disease. We compared methimazole (MMI) treatment with MMI + KI treatment in terms of rapid normalization of thyroid hormones during the early phase and examined the later induction of disease remission.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1365-2265
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
845-50
pubmed:meshHeading
pubmed-meshheading:19912243-Adult, pubmed-meshheading:19912243-Antithyroid Agents, pubmed-meshheading:19912243-Drug Administration Schedule, pubmed-meshheading:19912243-Drug Therapy, Combination, pubmed-meshheading:19912243-Female, pubmed-meshheading:19912243-Graves Disease, pubmed-meshheading:19912243-Humans, pubmed-meshheading:19912243-Male, pubmed-meshheading:19912243-Methimazole, pubmed-meshheading:19912243-Middle Aged, pubmed-meshheading:19912243-Potassium Iodide, pubmed-meshheading:19912243-Remission Induction, pubmed-meshheading:19912243-Risk Assessment, pubmed-meshheading:19912243-Thyroid Function Tests, pubmed-meshheading:19912243-Thyroid Hormones, pubmed-meshheading:19912243-Thyrotoxicosis, pubmed-meshheading:19912243-Time Factors, pubmed-meshheading:19912243-Treatment Outcome, pubmed-meshheading:19912243-Young Adult
pubmed:year
2010
pubmed:articleTitle
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
pubmed:affiliation
Kuma Hospital, Kobe, Japan. takata@kuma-h.or.jp
pubmed:publicationType
Journal Article, Randomized Controlled Trial